Published in Eur J Immunol on January 01, 2009
HuR uses AUF1 as a cofactor to promote p16INK4 mRNA decay. Mol Cell Biol (2010) 1.35
Reduced nuclear export of HuR mRNA by HuR is linked to the loss of HuR in replicative senescence. Nucleic Acids Res (2009) 1.16
Highly significant antiviral activity of HIV-1 LTR-specific tre-recombinase in humanized mice. PLoS Pathog (2013) 1.08
Using bacteria to determine protein kinase specificity and predict target substrates. PLoS One (2012) 0.88
RNA-binding protein HuR regulates RGS4 mRNA stability in rabbit colonic smooth muscle cells. Am J Physiol Cell Physiol (2010) 0.83
Post-transcriptional regulation of CD83 expression by AUF1 proteins. Nucleic Acids Res (2012) 0.83
FasL expression in activated T lymphocytes involves HuR-mediated stabilization. J Biol Chem (2010) 0.81
Functional characterization of the HuR:CD83 mRNA interaction. PLoS One (2011) 0.80
The human adenovirus type 5 E1B 55-kilodalton protein is phosphorylated by protein kinase CK2. J Virol (2011) 0.77
HIV-1 proviral DNA excision using an evolved recombinase. Science (2007) 2.81
Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approach. Blood (2006) 1.85
The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection. Proc Natl Acad Sci U S A (2009) 1.77
Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease. J Virol (2010) 1.61
A flow cytometry-based FRET assay to identify and analyse protein-protein interactions in living cells. PLoS One (2010) 1.54
CD83 on dendritic cells: more than just a marker for maturation. Trends Immunol (2002) 1.47
Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy. J Clin Invest (2005) 1.25
The strength of the HIV-1 3' splice sites affects Rev function. Retrovirology (2006) 1.24
Expression of CD83 is regulated by HuR via a novel cis-active coding region RNA element. J Biol Chem (2006) 1.15
The nuclear pore component Nup358 promotes transportin-dependent nuclear import. J Cell Sci (2009) 1.13
Intranuclear targeting and nuclear export of the adenovirus E1B-55K protein are regulated by SUMO1 conjugation. Proc Natl Acad Sci U S A (2007) 1.13
Multiple importins function as nuclear transport receptors for the Rev protein of human immunodeficiency virus type 1. J Biol Chem (2006) 1.11
Highly significant antiviral activity of HIV-1 LTR-specific tre-recombinase in humanized mice. PLoS Pathog (2013) 1.08
Analysis of nucleocytoplasmic trafficking of the HuR ligand APRIL and its influence on CD83 expression. J Biol Chem (2006) 1.06
A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses. J Infect Dis (2012) 1.05
Blockage of CRM1-dependent nuclear export of the adenovirus type 5 early region 1B 55-kDa protein augments oncogenic transformation of primary rat cells. Oncogene (2005) 1.03
A minimal uORF within the HIV-1 vpu leader allows efficient translation initiation at the downstream env AUG. Virology (2007) 1.02
SeLOX--a locus of recombination site search tool for the detection and directed evolution of site-specific recombination systems. Nucleic Acids Res (2010) 1.02
Proteomic profiling of germ cell cancer cells treated with aaptamine, a marine alkaloid with antiproliferative activity. J Proteome Res (2012) 0.97
Stimulated expression of mRNAs in activated T cells depends on a functional CRM1 nuclear export pathway. J Mol Biol (2006) 0.94
Decreased frequency of CD73+CD8+ T cells of HIV-infected patients correlates with immune activation and T cell exhaustion. J Leukoc Biol (2013) 0.91
Excision of HIV-1 proviral DNA by recombinant cell permeable tre-recombinase. PLoS One (2012) 0.89
Identification of two nuclear import signals in the alpha-gene product ICP22 of herpes simplex virus 1. Virology (2002) 0.89
Herpes simplex virus immediate-early protein ICP0 is targeted by SIAH-1 for proteasomal degradation. J Virol (2011) 0.88
Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies. PLoS One (2012) 0.88
The guanylhydrazone CNI-1493: an inhibitor with dual activity against malaria-inhibition of host cell pro-inflammatory cytokine release and parasitic deoxyhypusine synthase. Parasitol Res (2008) 0.86
Formation of trans-activation competent HIV-1 Rev:RRE complexes requires the recruitment of multiple protein activation domains. PLoS One (2012) 0.85
In vitro evolution and analysis of HIV-1 LTR-specific recombinases. Methods (2010) 0.85
Can we accurately quantify nanoparticle associated proteins when constructing high-affinity MRI molecular imaging probes? Contrast Media Mol Imaging (2011) 0.85
Inhibition of multidrug-resistant HIV-1 by interference with cellular S-adenosylmethionine decarboxylase activity. J Infect Dis (2006) 0.83
Engineered DNA modifying enzymes: components of a future strategy to cure HIV/AIDS. Antiviral Res (2012) 0.83
Post-transcriptional regulation of CD83 expression by AUF1 proteins. Nucleic Acids Res (2012) 0.83
Gene therapy strategies: can we eradicate HIV? Curr HIV/AIDS Rep (2011) 0.83
In vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway. BMC Microbiol (2012) 0.83
Engineering of a target site-specific recombinase by a combined evolution- and structure-guided approach. Nucleic Acids Res (2012) 0.82
Protein-protein-interaction network organization of the hypusine modification system. Mol Cell Proteomics (2012) 0.82
Screening assay for the identification of deoxyhypusine synthase inhibitors. J Biomol Screen (2004) 0.82
d(GGGT) 4 and r(GGGU) 4 are both HIV-1 inhibitors and interleukin-6 receptor aptamers. RNA Biol (2012) 0.81
Sustained virological response after early antiviral treatment of acute hepatitis C virus and HIV coinfection. Clin Infect Dis (2009) 0.81
The karyopherin CRM1 is required for dendritic cell maturation. Immunobiology (2009) 0.80
Functional characterization of the HuR:CD83 mRNA interaction. PLoS One (2011) 0.80
Preventing Fusarium head blight of wheat and cob rot of maize by inhibition of fungal deoxyhypusine synthase. Mol Plant Microbe Interact (2011) 0.79
In silico design, synthesis, and screening of novel deoxyhypusine synthase inhibitors targeting HIV-1 replication. ChemMedChem (2014) 0.78
Down-regulation of hypusine biosynthesis in Plasmodium by inhibition of S-adenosyl-methionine-decarboxylase. Amino Acids (2009) 0.78
Modification of eukaryotic initiation factor 5A from Plasmodium vivax by a truncated deoxyhypusine synthase from Plasmodium falciparum: An enzyme with dual enzymatic properties. Bioorg Med Chem (2007) 0.78
In search of novel agents for therapy of tropical diseases and human immunodeficiency virus. J Med Chem (2007) 0.77
Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemias. Invest New Drugs (2012) 0.76
[Eradication instead of only inhibiting. Is a totally new anti-HIV strategy evolving? (interview by Waldtraud Paukstadt)]. MMW Fortschr Med (2008) 0.75
Separation of lanthanides and actinides using magnetic silica particles bearing covalently attached tetra-CMPO-calix[4]arenes. Org Biomol Chem (2004) 0.75
Interview: HIV-1 proviral DNA excision using an evolved recombinase. J Vis Exp (2008) 0.75